Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

H19 Noncoding RNA, an Independent Prognostic Factor, Regulates Essential Rb-E2F and CDK8-β-Catenin Signaling in Colorectal Cancer

M. Ohtsuka, H. Ling, C. Ivan, M. Pichler, D. Matsushita, M. Goblirsch, V. Stiegelbauer, K. Shigeyasu, X. Zhang, M. Chen, F. Vidhu, GA. Bartholomeusz, Y. Toiyama, M. Kusunoki, Y. Doki, M. Mori, S. Song, JR. Gunther, S. Krishnan, O. Slaby, A. Goel,...

. 2016 ; 13 (-) : 113-124. [pub] 20161019

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17013439

The clinical significance of long noncoding RNAs (lncRNAs) in colorectal cancer (CRC) remains largely unexplored. Here, we analyzed a large panel of lncRNA candidates with The Cancer Genome Atlas (TCGA) CRC dataset, and identified H19 as the most significant lncRNA associated with CRC patient survival. We further validated such association in two independent CRC cohorts. H19 silencing blocked G1-S transition, reduced cell proliferation, and inhibited cell migration. We profiled gene expression changes to gain mechanism insight of H19 function. Transcriptome data analysis revealed not only previously identified mechanisms such as Let-7 regulation by H19, but also RB1-E2F1 function and β-catenin activity as essential upstream regulators mediating H19 function. Our experimental data showed that H19 affects phosphorylation of RB1 protein by regulating gene expression of CDK4 and CCND1. We further demonstrated that reduced CDK8 expression underlies changes of β-catenin activity, and identified that H19 interacts with macroH2A, an essential regulator of CDK8 gene transcription. However, the relevance of H19-macroH2A interaction in CDK8 regulation remains to be experimentally determined. We further explored the clinical relevance of above mechanisms in clinical samples, and showed that combined analysis of H19 with its targets improved prognostic value of H19 in CRC.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17013439
003      
CZ-PrNML
005      
20170428121143.0
007      
ta
008      
170413s2016 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ebiom.2016.10.026 $2 doi
035    __
$a (PubMed)27789274
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Ohtsuka, Masahisa $u Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
245    10
$a H19 Noncoding RNA, an Independent Prognostic Factor, Regulates Essential Rb-E2F and CDK8-β-Catenin Signaling in Colorectal Cancer / $c M. Ohtsuka, H. Ling, C. Ivan, M. Pichler, D. Matsushita, M. Goblirsch, V. Stiegelbauer, K. Shigeyasu, X. Zhang, M. Chen, F. Vidhu, GA. Bartholomeusz, Y. Toiyama, M. Kusunoki, Y. Doki, M. Mori, S. Song, JR. Gunther, S. Krishnan, O. Slaby, A. Goel, JA. Ajani, M. Radovich, GA. Calin,
520    9_
$a The clinical significance of long noncoding RNAs (lncRNAs) in colorectal cancer (CRC) remains largely unexplored. Here, we analyzed a large panel of lncRNA candidates with The Cancer Genome Atlas (TCGA) CRC dataset, and identified H19 as the most significant lncRNA associated with CRC patient survival. We further validated such association in two independent CRC cohorts. H19 silencing blocked G1-S transition, reduced cell proliferation, and inhibited cell migration. We profiled gene expression changes to gain mechanism insight of H19 function. Transcriptome data analysis revealed not only previously identified mechanisms such as Let-7 regulation by H19, but also RB1-E2F1 function and β-catenin activity as essential upstream regulators mediating H19 function. Our experimental data showed that H19 affects phosphorylation of RB1 protein by regulating gene expression of CDK4 and CCND1. We further demonstrated that reduced CDK8 expression underlies changes of β-catenin activity, and identified that H19 interacts with macroH2A, an essential regulator of CDK8 gene transcription. However, the relevance of H19-macroH2A interaction in CDK8 regulation remains to be experimentally determined. We further explored the clinical relevance of above mechanisms in clinical samples, and showed that combined analysis of H19 with its targets improved prognostic value of H19 in CRC.
650    _2
$a zvířata $7 D000818
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a kolorektální nádory $x genetika $x metabolismus $x mortalita $x patologie $7 D015179
650    _2
$a cyklin-dependentní kinasa 8 $x genetika $x metabolismus $7 D056850
650    _2
$a databáze nukleových kyselin $7 D030561
650    _2
$a transkripční faktory E2F $x metabolismus $7 D050684
650    _2
$a stanovení celkové genové exprese $7 D020869
650    _2
$a regulace genové exprese u nádorů $7 D015972
650    _2
$a genové regulační sítě $7 D053263
650    _2
$a lidé $7 D006801
650    _2
$a myši $7 D051379
650    _2
$a prognóza $7 D011379
650    _2
$a RNA interference $7 D034622
650    _2
$a RNA dlouhá nekódující $x genetika $7 D062085
650    _2
$a retinoblastomový protein $x metabolismus $7 D016160
650    12
$a signální transdukce $7 D015398
650    _2
$a analýza přežití $7 D016019
650    _2
$a transkriptom $7 D059467
650    _2
$a beta-katenin $x metabolismus $7 D051176
655    _2
$a časopisecké články $7 D016428
700    1_
$a Ling, Hui $u Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: hling@mdanderson.org.
700    1_
$a Ivan, Cristina $u Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
700    1_
$a Pichler, Martin $u Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Research Unit for non-coding RNA and genome editing, Division of Oncology, Medical University of Graz, Austria.
700    1_
$a Matsushita, Daisuke $u Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
700    1_
$a Goblirsch, Matthew $u Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
700    1_
$a Stiegelbauer, Verena $u Research Unit for non-coding RNA and genome editing, Division of Oncology, Medical University of Graz, Austria.
700    1_
$a Shigeyasu, Kunitoshi $u Center for Gastrointestinal Research, Baylor Research Institute and Charles A. Sammons Cancer Center, Baylor University Medical Center, Dallas, TX, USA.
700    1_
$a Zhang, Xinna $u Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
700    1_
$a Chen, Meng $u Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
700    1_
$a Vidhu, Fnu $u Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
700    1_
$a Bartholomeusz, Geoffrey A $u Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
700    1_
$a Toiyama, Yuji $u Department of Gastrointestinal and Pediatric Surgery, Division of Reparative Medicine, Institute of Life Sciences, Mie University Graduate School of Medicine, Mie, Japan.
700    1_
$a Kusunoki, Masato $u Department of Gastrointestinal and Pediatric Surgery, Division of Reparative Medicine, Institute of Life Sciences, Mie University Graduate School of Medicine, Mie, Japan.
700    1_
$a Doki, Yuichiro $u Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan.
700    1_
$a Mori, Masaki $u Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan.
700    1_
$a Song, Shumei $u Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
700    1_
$a Gunther, Jillian R $u Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
700    1_
$a Krishnan, Sunil $u Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
700    1_
$a Slaby, Ondrej $u Central European Institute of Technology, Molecular Oncology II, Masaryk University, Brno, Czech Republic.
700    1_
$a Goel, Ajay $u Center for Gastrointestinal Research, Baylor Research Institute and Charles A. Sammons Cancer Center, Baylor University Medical Center, Dallas, TX, USA.
700    1_
$a Ajani, Jaffer A $u Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. $7 gn_A_00002768
700    1_
$a Radovich, Milan $u Department of Surgery, Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA.
700    1_
$a Calin, George A $u Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: gcalin@mdanderson.org.
773    0_
$w MED00190061 $t EBioMedicine $x 2352-3964 $g Roč. 13, č. - (2016), s. 113-124
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27789274 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170413 $b ABA008
991    __
$a 20170428121505 $b ABA008
999    __
$a ok $b bmc $g 1199904 $s 974217
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 13 $c - $d 113-124 $e 20161019 $i 2352-3964 $m EBioMedicine $n EBioMedicine $x MED00190061
LZP    __
$a Pubmed-20170413

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace